

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | nuclear pore complex assembly (GO:0051292) | 5.20852183 |
| 2 | establishment of protein localization to Golgi (GO:0072600) | 5.09453990 |
| 3 | protein targeting to Golgi (GO:0000042) | 5.08741287 |
| 4 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 4.89349831 |
| 5 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.78660350 |
| 6 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.78660350 |
| 7 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.77077882 |
| 8 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.61730888 |
| 9 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.38350828 |
| 10 | nuclear pore organization (GO:0006999) | 4.17555622 |
| 11 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.95798662 |
| 12 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.95798662 |
| 13 | modulation by symbiont of host immune response (GO:0052553) | 3.95798662 |
| 14 | positive regulation by symbiont of host defense response (GO:0052509) | 3.95798662 |
| 15 | modulation by symbiont of host defense response (GO:0052031) | 3.95798662 |
| 16 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.95798662 |
| 17 | neutrophil activation involved in immune response (GO:0002283) | 3.84053584 |
| 18 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 3.79853943 |
| 19 | response to type I interferon (GO:0034340) | 3.76646118 |
| 20 | monoubiquitinated protein deubiquitination (GO:0035520) | 3.76501871 |
| 21 | leukocyte aggregation (GO:0070486) | 3.75897846 |
| 22 | cellular response to type I interferon (GO:0071357) | 3.68333208 |
| 23 | type I interferon signaling pathway (GO:0060337) | 3.68333208 |
| 24 | muscle filament sliding (GO:0030049) | 3.66758381 |
| 25 | actin-myosin filament sliding (GO:0033275) | 3.66758381 |
| 26 | pore complex assembly (GO:0046931) | 3.64712737 |
| 27 | histone H3-K36 demethylation (GO:0070544) | 3.62971513 |
| 28 | interkinetic nuclear migration (GO:0022027) | 3.62635276 |
| 29 | response to peptidoglycan (GO:0032494) | 3.58558822 |
| 30 | positive regulation of interferon-alpha production (GO:0032727) | 3.53361836 |
| 31 | regulation of gamma-delta T cell activation (GO:0046643) | 3.51090719 |
| 32 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.49965934 |
| 33 | T cell migration (GO:0072678) | 3.44507644 |
| 34 | regulation of interferon-alpha production (GO:0032647) | 3.42836746 |
| 35 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.42541548 |
| 36 | histone H3-K9 demethylation (GO:0033169) | 3.42169115 |
| 37 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.41463969 |
| 38 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.33211180 |
| 39 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 3.30033826 |
| 40 | response to muramyl dipeptide (GO:0032495) | 3.27051469 |
| 41 | cellular response to ethanol (GO:0071361) | 3.26117646 |
| 42 | neutrophil activation (GO:0042119) | 3.25961630 |
| 43 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.25476902 |
| 44 | actin-mediated cell contraction (GO:0070252) | 3.25370284 |
| 45 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.24283302 |
| 46 | interferon-gamma production (GO:0032609) | 3.22980719 |
| 47 | granulocyte activation (GO:0036230) | 3.20208750 |
| 48 | Golgi to endosome transport (GO:0006895) | 3.19430798 |
| 49 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 3.17383713 |
| 50 | regulation of relaxation of muscle (GO:1901077) | 3.16564372 |
| 51 | skeletal muscle adaptation (GO:0043501) | 3.16010305 |
| 52 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.15465645 |
| 53 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.14739964 |
| 54 | respiratory burst (GO:0045730) | 3.14502617 |
| 55 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.09498631 |
| 56 | negative regulation of cell killing (GO:0031342) | 3.09498631 |
| 57 | myofibril assembly (GO:0030239) | 3.06298413 |
| 58 | protein localization to Golgi apparatus (GO:0034067) | 3.04777797 |
| 59 | cellular extravasation (GO:0045123) | 3.04613216 |
| 60 | negative regulation of inclusion body assembly (GO:0090084) | 3.03750447 |
| 61 | actin filament-based movement (GO:0030048) | 3.00052962 |
| 62 | detection of molecule of bacterial origin (GO:0032490) | 2.99445529 |
| 63 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.98997150 |
| 64 | histone mRNA catabolic process (GO:0071044) | 2.97545696 |
| 65 | T-helper 1 type immune response (GO:0042088) | 2.97524750 |
| 66 | mature B cell differentiation (GO:0002335) | 2.96549067 |
| 67 | regulation of necroptotic process (GO:0060544) | 2.93497354 |
| 68 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.92635851 |
| 69 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.92331552 |
| 70 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.92317478 |
| 71 | skeletal muscle contraction (GO:0003009) | 2.91879591 |
| 72 | immunoglobulin mediated immune response (GO:0016064) | 2.91673129 |
| 73 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.91211187 |
| 74 | positive regulation of antigen processing and presentation (GO:0002579) | 2.89981912 |
| 75 | negative T cell selection (GO:0043383) | 2.89511111 |
| 76 | definitive hemopoiesis (GO:0060216) | 2.85096622 |
| 77 | positive thymic T cell selection (GO:0045059) | 2.84875589 |
| 78 | positive regulation of B cell differentiation (GO:0045579) | 2.83608779 |
| 79 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 2.83413542 |
| 80 | negative thymic T cell selection (GO:0045060) | 2.81125606 |
| 81 | tolerance induction (GO:0002507) | 2.75670782 |
| 82 | response to interferon-alpha (GO:0035455) | 2.74867798 |
| 83 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.74021211 |
| 84 | response to interleukin-15 (GO:0070672) | 2.73455097 |
| 85 | early endosome to late endosome transport (GO:0045022) | 2.72487822 |
| 86 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.72438631 |
| 87 | myeloid cell activation involved in immune response (GO:0002275) | 2.71590818 |
| 88 | macrophage activation involved in immune response (GO:0002281) | 2.71550916 |
| 89 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.71287295 |
| 90 | positive regulation of T cell cytokine production (GO:0002726) | 2.70988163 |
| 91 | growth hormone receptor signaling pathway (GO:0060396) | 2.70652207 |
| 92 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.69961961 |
| 93 | response to host immune response (GO:0052572) | 2.69961961 |
| 94 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.67324513 |
| 95 | positive regulation of interleukin-2 production (GO:0032743) | 2.66749812 |
| 96 | histone lysine demethylation (GO:0070076) | 2.65956083 |
| 97 | regulation of T cell tolerance induction (GO:0002664) | 2.65493324 |
| 98 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.65386656 |
| 99 | defense response to protozoan (GO:0042832) | 2.65328310 |
| 100 | cellular response to zinc ion (GO:0071294) | 2.65070234 |
| 101 | response to protozoan (GO:0001562) | 2.64878726 |
| 102 | B cell receptor signaling pathway (GO:0050853) | 2.63844211 |
| 103 | regulation of histone H3-K27 methylation (GO:0061085) | 2.63130457 |
| 104 | striated muscle atrophy (GO:0014891) | 2.62935330 |
| 105 | nucleus organization (GO:0006997) | 2.62738459 |
| 106 | hepatocyte apoptotic process (GO:0097284) | 2.62676425 |
| 107 | positive regulation of interleukin-17 production (GO:0032740) | 2.61426823 |
| 108 | regulation of B cell differentiation (GO:0045577) | 2.60602887 |
| 109 | leukocyte cell-cell adhesion (GO:0007159) | 2.60377607 |
| 110 | glomerular visceral epithelial cell development (GO:0072015) | 2.59238920 |
| 111 | cellular response to interleukin-15 (GO:0071350) | 2.58721647 |
| 112 | cellular response to virus (GO:0098586) | 2.58549412 |
| 113 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.56308996 |
| 114 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.56077258 |
| 115 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.55754941 |
| 116 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 2.55544480 |
| 117 | pinocytosis (GO:0006907) | 2.54789091 |
| 118 | regulation of centriole replication (GO:0046599) | 2.54681533 |
| 119 | dendritic cell chemotaxis (GO:0002407) | 2.54280985 |
| 120 | positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 2.53323385 |
| 121 | cellular response to exogenous dsRNA (GO:0071360) | 2.53318166 |
| 122 | negative regulation of DNA repair (GO:0045738) | 2.53302259 |
| 123 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.53282003 |
| 124 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.53078729 |
| 125 | myeloid dendritic cell activation (GO:0001773) | 2.52817273 |
| 126 | regulation of hypersensitivity (GO:0002883) | 2.52425064 |
| 127 | negative regulation of viral genome replication (GO:0045071) | 2.52243028 |
| 128 | embryonic process involved in female pregnancy (GO:0060136) | 2.51866310 |
| 129 | response to host (GO:0075136) | 2.51195918 |
| 130 | response to host defenses (GO:0052200) | 2.51195918 |
| 131 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.51195918 |
| 132 | histone demethylation (GO:0016577) | 2.50656255 |
| 133 | DNA packaging (GO:0006323) | 2.50464546 |
| 134 | NIK/NF-kappaB signaling (GO:0038061) | 2.48776309 |
| 135 | positive regulation of T-helper cell differentiation (GO:0045624) | 2.48343862 |
| 136 | regulation of skeletal muscle contraction (GO:0014819) | 2.48074675 |
| 137 | thymic T cell selection (GO:0045061) | 2.47173122 |
| 138 | regulation of protein polyubiquitination (GO:1902914) | 2.47113593 |
| 139 | macrophage activation (GO:0042116) | 2.47082148 |
| 140 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.46782893 |
| 141 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.46742534 |
| 142 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.46742534 |
| 143 | hypotonic response (GO:0006971) | 2.46478068 |
| 144 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.46148204 |
| 145 | natural killer cell mediated immunity (GO:0002228) | 2.46148204 |
| 146 | positive regulation of defense response to virus by host (GO:0002230) | 2.45623841 |
| 147 | T cell selection (GO:0045058) | 2.45479983 |
| 148 | negative regulation of necroptotic process (GO:0060546) | 2.45236467 |
| 149 | microglial cell activation (GO:0001774) | 2.45233662 |
| 150 | positive regulation of type 2 immune response (GO:0002830) | 2.45144779 |
| 151 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.45112758 |
| 152 | positive regulation of myotube differentiation (GO:0010831) | 2.43934009 |
| 153 | detection of other organism (GO:0098543) | 2.42680466 |
| 154 | NLS-bearing protein import into nucleus (GO:0006607) | 2.41629476 |
| 155 | cellular response to epinephrine stimulus (GO:0071872) | 2.40798658 |
| 156 | chromosome condensation (GO:0030261) | 2.39794012 |
| 157 | regulation of establishment of cell polarity (GO:2000114) | 2.39474335 |
| 158 | sperm motility (GO:0030317) | 2.39304964 |
| 159 | fusion of sperm to egg plasma membrane (GO:0007342) | 2.38717979 |
| 160 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.38319892 |
| 161 | cellular response to growth hormone stimulus (GO:0071378) | 2.38142193 |
| 162 | negative regulation of NF-kappaB import into nucleus (GO:0042347) | 2.35278939 |
| 163 | iron ion import (GO:0097286) | 2.35274155 |
| 164 | sarcomere organization (GO:0045214) | 2.35268518 |
| 165 | skeletal muscle tissue regeneration (GO:0043403) | 2.35157956 |
| 166 | detection of external biotic stimulus (GO:0098581) | 2.33515528 |
| 167 | cardiac muscle hypertrophy (GO:0003300) | 2.33121952 |
| 168 | response to epinephrine (GO:0071871) | 2.31689738 |
| 169 | positive T cell selection (GO:0043368) | 2.31118672 |
| 170 | negative regulation of T cell mediated immunity (GO:0002710) | 2.30317981 |
| 171 | regulation of Rab GTPase activity (GO:0032313) | 2.30302975 |
| 172 | positive regulation of Rab GTPase activity (GO:0032851) | 2.30302975 |
| 173 | cytoplasmic mRNA processing body assembly (GO:0033962) | 2.30169023 |
| 174 | nucleus localization (GO:0051647) | 2.30106275 |
| 175 | regulation of RNA export from nucleus (GO:0046831) | 2.30030014 |
| 176 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.29733982 |
| 177 | acrosome reaction (GO:0007340) | 2.29288142 |
| 178 | muscle atrophy (GO:0014889) | 2.28599905 |
| 179 | striated muscle adaptation (GO:0014888) | 2.27409723 |
| 180 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.26882873 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 5.61873624 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.28456643 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.65609065 |
| 4 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.34620310 |
| 5 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.99547513 |
| 6 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.99431431 |
| 7 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.53674216 |
| 8 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.46640649 |
| 9 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.22827287 |
| 10 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 3.10338786 |
| 11 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.08115590 |
| 12 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.02331528 |
| 13 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.96836540 |
| 14 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.79562181 |
| 15 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.74399983 |
| 16 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.55065671 |
| 17 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.54751610 |
| 18 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.48355195 |
| 19 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.45923887 |
| 20 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.40740789 |
| 21 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.37935275 |
| 22 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.32597307 |
| 23 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.29186385 |
| 24 | GATA1_22025678_ChIP-Seq_K562_Human | 2.25833539 |
| 25 | * MYB_26560356_Chip-Seq_TH2_Human | 2.23329276 |
| 26 | MAF_26560356_Chip-Seq_TH1_Human | 2.05098073 |
| 27 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.98065202 |
| 28 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.88063209 |
| 29 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.86843471 |
| 30 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.82882468 |
| 31 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.80377103 |
| 32 | * MYB_26560356_Chip-Seq_TH1_Human | 1.76290802 |
| 33 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.76039583 |
| 34 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.68208167 |
| 35 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.67380449 |
| 36 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.62439939 |
| 37 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.61372169 |
| 38 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.60717648 |
| 39 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.57400563 |
| 40 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.56713751 |
| 41 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.55910428 |
| 42 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.55330461 |
| 43 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.55201775 |
| 44 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.52712914 |
| 45 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.49102649 |
| 46 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.48439748 |
| 47 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.47336028 |
| 48 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.43237781 |
| 49 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.41173865 |
| 50 | GATA1_19941826_ChIP-Seq_K562_Human | 1.40351293 |
| 51 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.39935609 |
| 52 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.39696431 |
| 53 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.39002146 |
| 54 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.38509936 |
| 55 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.36623459 |
| 56 | SPI1_23127762_ChIP-Seq_K562_Human | 1.34940127 |
| 57 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.34720662 |
| 58 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.32605344 |
| 59 | STAT3_23295773_ChIP-Seq_U87_Human | 1.32529219 |
| 60 | GATA2_19941826_ChIP-Seq_K562_Human | 1.31183620 |
| 61 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.30991166 |
| 62 | * ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.30087759 |
| 63 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.30066120 |
| 64 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.29586898 |
| 65 | FUS_26573619_Chip-Seq_HEK293_Human | 1.29358756 |
| 66 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.27440110 |
| 67 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.27101447 |
| 68 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.26854338 |
| 69 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.23879799 |
| 70 | TP63_23658742_ChIP-Seq_EP156T_Human | 1.22947739 |
| 71 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.21811308 |
| 72 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.21524195 |
| 73 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.21367922 |
| 74 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.19761216 |
| 75 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.19615395 |
| 76 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.19455304 |
| 77 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.19014434 |
| 78 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.18772167 |
| 79 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.18713882 |
| 80 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.17095399 |
| 81 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.16687231 |
| 82 | * BRD4_25478319_ChIP-Seq_HGPS_Human | 1.16007297 |
| 83 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.14460214 |
| 84 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.13543289 |
| 85 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.13155343 |
| 86 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.12523115 |
| 87 | * CJUN_26792858_Chip-Seq_BT549_Human | 1.12506716 |
| 88 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.12418046 |
| 89 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.11898694 |
| 90 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.11551552 |
| 91 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.11551552 |
| 92 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.11537347 |
| 93 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.11148770 |
| 94 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.10968256 |
| 95 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.10800232 |
| 96 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.10486936 |
| 97 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.10268921 |
| 98 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.09917039 |
| 99 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.09183368 |
| 100 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.08603548 |
| 101 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.07794826 |
| 102 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.07370668 |
| 103 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.06929469 |
| 104 | * TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.06456223 |
| 105 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.06364512 |
| 106 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.06109268 |
| 107 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.05712833 |
| 108 | MAF_26560356_Chip-Seq_TH2_Human | 1.05042109 |
| 109 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.04701657 |
| 110 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.04403996 |
| 111 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.04254045 |
| 112 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.04096573 |
| 113 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.03648324 |
| 114 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.03648324 |
| 115 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.03402567 |
| 116 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.03382593 |
| 117 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.03356976 |
| 118 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.02537763 |
| 119 | * GATA3_26560356_Chip-Seq_TH2_Human | 1.02227584 |
| 120 | * KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 1.01775176 |
| 121 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 1.01505520 |
| 122 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.01260455 |
| 123 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.00625819 |
| 124 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.98881696 |
| 125 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.98811786 |
| 126 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.98518957 |
| 127 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 0.98024144 |
| 128 | P300_19829295_ChIP-Seq_ESCs_Human | 0.97245802 |
| 129 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.97194541 |
| 130 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.96997835 |
| 131 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.96943524 |
| 132 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.96943524 |
| 133 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.95795218 |
| 134 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.95261050 |
| 135 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.95261050 |
| 136 | * CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.95005397 |
| 137 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.94699888 |
| 138 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.94471879 |
| 139 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.93156870 |
| 140 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.93107139 |
| 141 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.90980267 |
| 142 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.90555915 |
| 143 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.89843582 |
| 144 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.88845649 |
| 145 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.88414679 |
| 146 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.86928170 |
| 147 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.86697378 |
| 148 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.85897214 |
| 149 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.85645772 |
| 150 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.85581416 |
| 151 | MYC_22102868_ChIP-Seq_BL_Human | 0.85194831 |
| 152 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.83154235 |
| 153 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.82392328 |
| 154 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.82334427 |
| 155 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.81869276 |
| 156 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.80803656 |
| 157 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.78221698 |
| 158 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.76589229 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0008057_abnormal_DNA_replication | 3.66718213 |
| 2 | MP0001835_abnormal_antigen_presentation | 3.48370696 |
| 3 | MP0003646_muscle_fatigue | 3.47689932 |
| 4 | MP0009785_altered_susceptibility_to | 3.27652593 |
| 5 | MP0003724_increased_susceptibility_to | 2.91548736 |
| 6 | MP0003436_decreased_susceptibility_to | 2.83552341 |
| 7 | MP0003303_peritoneal_inflammation | 2.81531552 |
| 8 | MP0000569_abnormal_digit_pigmentation | 2.78880202 |
| 9 | MP0000685_abnormal_immune_system | 2.75004107 |
| 10 | MP0005671_abnormal_response_to | 2.73824491 |
| 11 | MP0005387_immune_system_phenotype | 2.73238435 |
| 12 | MP0001790_abnormal_immune_system | 2.73238435 |
| 13 | MP0005000_abnormal_immune_tolerance | 2.69679847 |
| 14 | MP0004036_abnormal_muscle_relaxation | 2.68950792 |
| 15 | MP0005025_abnormal_response_to | 2.63437881 |
| 16 | MP0002166_altered_tumor_susceptibility | 2.61318981 |
| 17 | MP0002148_abnormal_hypersensitivity_rea | 2.56904807 |
| 18 | MP0001800_abnormal_humoral_immune | 2.53333739 |
| 19 | MP0004084_abnormal_cardiac_muscle | 2.49640874 |
| 20 | MP0002419_abnormal_innate_immunity | 2.47312341 |
| 21 | MP0002452_abnormal_antigen_presenting | 2.38615841 |
| 22 | MP0005670_abnormal_white_adipose | 2.34781440 |
| 23 | MP0002723_abnormal_immune_serum | 2.34171754 |
| 24 | MP0006082_CNS_inflammation | 2.34081248 |
| 25 | MP0005410_abnormal_fertilization | 2.31558065 |
| 26 | MP0000749_muscle_degeneration | 2.24808381 |
| 27 | MP0002006_tumorigenesis | 2.21003453 |
| 28 | MP0001819_abnormal_immune_cell | 2.16174449 |
| 29 | MP0002420_abnormal_adaptive_immunity | 2.15593915 |
| 30 | MP0003656_abnormal_erythrocyte_physiolo | 2.09522069 |
| 31 | MP0003300_gastrointestinal_ulcer | 2.06985244 |
| 32 | MP0003763_abnormal_thymus_physiology | 2.03221177 |
| 33 | MP0004145_abnormal_muscle_electrophysio | 2.02287653 |
| 34 | MP0004947_skin_inflammation | 1.98287641 |
| 35 | MP0004381_abnormal_hair_follicle | 1.96971634 |
| 36 | MP0002009_preneoplasia | 1.94625910 |
| 37 | MP0004510_myositis | 1.90216284 |
| 38 | MP0004233_abnormal_muscle_weight | 1.86879260 |
| 39 | MP0002332_abnormal_exercise_endurance | 1.86585162 |
| 40 | MP0004484_altered_response_of | 1.83874620 |
| 41 | MP0010155_abnormal_intestine_physiology | 1.73798723 |
| 42 | MP0004087_abnormal_muscle_fiber | 1.73333469 |
| 43 | MP0002398_abnormal_bone_marrow | 1.73121895 |
| 44 | MP0005464_abnormal_platelet_physiology | 1.72070830 |
| 45 | MP0005666_abnormal_adipose_tissue | 1.71958590 |
| 46 | MP0002405_respiratory_system_inflammati | 1.70430386 |
| 47 | MP0000716_abnormal_immune_system | 1.69091291 |
| 48 | MP0002269_muscular_atrophy | 1.65441169 |
| 49 | MP0001845_abnormal_inflammatory_respons | 1.62497211 |
| 50 | MP0003448_altered_tumor_morphology | 1.60704620 |
| 51 | MP0001853_heart_inflammation | 1.60213617 |
| 52 | MP0010234_abnormal_vibrissa_follicle | 1.59129964 |
| 53 | MP0001533_abnormal_skeleton_physiology | 1.58764520 |
| 54 | MP0000759_abnormal_skeletal_muscle | 1.54102297 |
| 55 | MP0003221_abnormal_cardiomyocyte_apopto | 1.53655692 |
| 56 | MP0003705_abnormal_hypodermis_morpholog | 1.50286222 |
| 57 | MP0009278_abnormal_bone_marrow | 1.49724556 |
| 58 | MP0009764_decreased_sensitivity_to | 1.47951457 |
| 59 | MP0004147_increased_porphyrin_level | 1.47374497 |
| 60 | MP0009333_abnormal_splenocyte_physiolog | 1.46476165 |
| 61 | MP0000751_myopathy | 1.46164453 |
| 62 | MP0000343_altered_response_to | 1.44850431 |
| 63 | MP0003453_abnormal_keratinocyte_physiol | 1.43555054 |
| 64 | MP0002106_abnormal_muscle_physiology | 1.43533094 |
| 65 | MP0008260_abnormal_autophagy | 1.42798707 |
| 66 | MP0001545_abnormal_hematopoietic_system | 1.42422828 |
| 67 | MP0005397_hematopoietic_system_phenotyp | 1.42422828 |
| 68 | MP0008469_abnormal_protein_level | 1.41207281 |
| 69 | MP0001851_eye_inflammation | 1.40863856 |
| 70 | MP0000689_abnormal_spleen_morphology | 1.40184020 |
| 71 | MP0002722_abnormal_immune_system | 1.39512308 |
| 72 | MP0005058_abnormal_lysosome_morphology | 1.38979555 |
| 73 | MP0002429_abnormal_blood_cell | 1.38474631 |
| 74 | MP0000465_gastrointestinal_hemorrhage | 1.34663097 |
| 75 | MP0005375_adipose_tissue_phenotype | 1.32279260 |
| 76 | MP0009115_abnormal_fat_cell | 1.30968726 |
| 77 | MP0000747_muscle_weakness | 1.28548132 |
| 78 | MP0006138_congestive_heart_failure | 1.27176529 |
| 79 | MP0005620_abnormal_muscle_contractility | 1.27094659 |
| 80 | MP0000858_altered_metastatic_potential | 1.26657600 |
| 81 | MP0002933_joint_inflammation | 1.25808955 |
| 82 | MP0000383_abnormal_hair_follicle | 1.25616203 |
| 83 | MP0002998_abnormal_bone_remodeling | 1.23950097 |
| 84 | MP0003828_pulmonary_edema | 1.23485386 |
| 85 | MP0010630_abnormal_cardiac_muscle | 1.22281569 |
| 86 | MP0001873_stomach_inflammation | 1.21107445 |
| 87 | MP0002971_abnormal_brown_adipose | 1.20938878 |
| 88 | MP0005369_muscle_phenotype | 1.14861871 |
| 89 | MP0002396_abnormal_hematopoietic_system | 1.14145573 |
| 90 | MP0003136_yellow_coat_color | 1.12361774 |
| 91 | MP0002972_abnormal_cardiac_muscle | 1.10476063 |
| 92 | MP0002127_abnormal_cardiovascular_syste | 1.09428031 |
| 93 | MP0000703_abnormal_thymus_morphology | 1.05546577 |
| 94 | MP0004808_abnormal_hematopoietic_stem | 1.03738436 |
| 95 | MP0000920_abnormal_myelination | 1.03608779 |
| 96 | MP0005174_abnormal_tail_pigmentation | 1.02545303 |
| 97 | MP0002877_abnormal_melanocyte_morpholog | 0.99810242 |
| 98 | MP0010678_abnormal_skin_adnexa | 0.99573120 |
| 99 | MP0009763_increased_sensitivity_to | 0.96400341 |
| 100 | MP0005266_abnormal_metabolism | 0.95197137 |
| 101 | MP0004215_abnormal_myocardial_fiber | 0.93476057 |
| 102 | MP0005409_darkened_coat_color | 0.93046437 |
| 103 | MP0002138_abnormal_hepatobiliary_system | 0.92580226 |
| 104 | MP0005166_decreased_susceptibility_to | 0.92283789 |
| 105 | MP0003566_abnormal_cell_adhesion | 0.92117807 |
| 106 | MP0002108_abnormal_muscle_morphology | 0.89674152 |
| 107 | MP0003191_abnormal_cellular_cholesterol | 0.89625894 |
| 108 | MP0001879_abnormal_lymphatic_vessel | 0.89495480 |
| 109 | MP0000013_abnormal_adipose_tissue | 0.88735220 |
| 110 | MP0003866_abnormal_defecation | 0.88084979 |
| 111 | MP0003075_altered_response_to | 0.88017680 |
| 112 | MP0004185_abnormal_adipocyte_glucose | 0.87365908 |
| 113 | MP0004883_abnormal_blood_vessel | 0.87004939 |
| 114 | MP0002277_abnormal_respiratory_mucosa | 0.86017317 |
| 115 | MP0001661_extended_life_span | 0.84461218 |
| 116 | MP0005076_abnormal_cell_differentiation | 0.84383719 |
| 117 | MP0003950_abnormal_plasma_membrane | 0.84324394 |
| 118 | MP0005310_abnormal_salivary_gland | 0.83360075 |
| 119 | MP0001216_abnormal_epidermal_layer | 0.82619690 |
| 120 | MP0002168_other_aberrant_phenotype | 0.82488258 |
| 121 | MP0003690_abnormal_glial_cell | 0.82289188 |
| 122 | MP0005330_cardiomyopathy | 0.79499038 |
| 123 | MP0000490_abnormal_crypts_of | 0.79032745 |
| 124 | MP0004130_abnormal_muscle_cell | 0.78182939 |
| 125 | MP0000003_abnormal_adipose_tissue | 0.77724047 |
| 126 | MP0003183_abnormal_peptide_metabolism | 0.76173129 |
| 127 | MP0002254_reproductive_system_inflammat | 0.75442826 |
| 128 | MP0005451_abnormal_body_composition | 0.75249384 |
| 129 | MP0005385_cardiovascular_system_phenoty | 0.74901442 |
| 130 | MP0001544_abnormal_cardiovascular_syste | 0.74901442 |
| 131 | MP0003045_fibrosis | 0.74754645 |
| 132 | MP0005023_abnormal_wound_healing | 0.73949848 |
| 133 | MP0004264_abnormal_extraembryonic_tissu | 0.73518828 |
| 134 | MP0005275_abnormal_skin_tensile | 0.72978092 |
| 135 | MP0000249_abnormal_blood_vessel | 0.72421119 |
| 136 | MP0005390_skeleton_phenotype | 0.71868967 |
| 137 | MP0003091_abnormal_cell_migration | 0.71848139 |
| 138 | MP0009697_abnormal_copulation | 0.70105969 |
| 139 | MP0001191_abnormal_skin_condition | 0.69759061 |
| 140 | MP0009931_abnormal_skin_appearance | 0.69501138 |
| 141 | MP0002796_impaired_skin_barrier | 0.68673547 |
| 142 | MP0000767_abnormal_smooth_muscle | 0.68480963 |
| 143 | MP0005164_abnormal_response_to | 0.67217396 |
| 144 | MP0009840_abnormal_foam_cell | 0.66554634 |
| 145 | MP0010352_gastrointestinal_tract_polyps | 0.66231688 |
| 146 | MP0008438_abnormal_cutaneous_collagen | 0.65182459 |
| 147 | MP0000733_abnormal_muscle_development | 0.64636544 |
| 148 | MP0010307_abnormal_tumor_latency | 0.64586445 |
| 149 | MP0001663_abnormal_digestive_system | 0.64377198 |
| 150 | MP0000372_irregular_coat_pigmentation | 0.64286433 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nemaline bodies (HP:0003798) | 6.10161506 |
| 2 | Muscle fiber inclusion bodies (HP:0100299) | 6.04237011 |
| 3 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 5.87390884 |
| 4 | Eczematoid dermatitis (HP:0000976) | 5.31125969 |
| 5 | Recurrent abscess formation (HP:0002722) | 4.72841647 |
| 6 | Type 1 muscle fiber predominance (HP:0003803) | 4.38137317 |
| 7 | Recurrent bacterial skin infections (HP:0005406) | 4.30497740 |
| 8 | Exercise-induced myalgia (HP:0003738) | 4.25037613 |
| 9 | Subaortic stenosis (HP:0001682) | 4.15870114 |
| 10 | Abnormality of the left ventricular outflow tract (HP:0011103) | 4.15870114 |
| 11 | Chronic otitis media (HP:0000389) | 3.99529671 |
| 12 | Recurrent fungal infections (HP:0002841) | 3.94869311 |
| 13 | Hyperkalemia (HP:0002153) | 3.89071979 |
| 14 | Asymmetric septal hypertrophy (HP:0001670) | 3.85395568 |
| 15 | Recurrent viral infections (HP:0004429) | 3.79167452 |
| 16 | Stomatitis (HP:0010280) | 3.75435547 |
| 17 | Myositis (HP:0100614) | 3.73543944 |
| 18 | Abnormality of macrophages (HP:0004311) | 3.73178381 |
| 19 | Autoimmune thrombocytopenia (HP:0001973) | 3.72882766 |
| 20 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.70396112 |
| 21 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.69373743 |
| 22 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 3.62927318 |
| 23 | Papillary thyroid carcinoma (HP:0002895) | 3.54618155 |
| 24 | Recurrent skin infections (HP:0001581) | 3.53896485 |
| 25 | Spontaneous hematomas (HP:0007420) | 3.53131574 |
| 26 | Mediastinal lymphadenopathy (HP:0100721) | 3.47963088 |
| 27 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.44317369 |
| 28 | Recurrent cutaneous fungal infections (HP:0011370) | 3.44317369 |
| 29 | Calf muscle hypertrophy (HP:0008981) | 3.38376096 |
| 30 | Vasculitis (HP:0002633) | 3.38106818 |
| 31 | Orchitis (HP:0100796) | 3.32689211 |
| 32 | Chronic obstructive pulmonary disease (HP:0006510) | 3.30511590 |
| 33 | Obstructive lung disease (HP:0006536) | 3.30511590 |
| 34 | Optic neuritis (HP:0100653) | 3.25697168 |
| 35 | Retrobulbar optic neuritis (HP:0100654) | 3.25697168 |
| 36 | Difficulty running (HP:0009046) | 3.23369647 |
| 37 | Distal arthrogryposis (HP:0005684) | 3.18964362 |
| 38 | Abnormality of T cell number (HP:0011839) | 3.18378724 |
| 39 | Cellulitis (HP:0100658) | 3.14351139 |
| 40 | T lymphocytopenia (HP:0005403) | 3.13644958 |
| 41 | Increased IgE level (HP:0003212) | 3.07920905 |
| 42 | Meningitis (HP:0001287) | 3.07702525 |
| 43 | Recurrent bronchitis (HP:0002837) | 3.06394662 |
| 44 | Nasal polyposis (HP:0100582) | 3.01395683 |
| 45 | Abnormality of the nasal mucosa (HP:0000433) | 2.99972331 |
| 46 | EMG: myopathic abnormalities (HP:0003458) | 2.98891658 |
| 47 | Muscle fiber splitting (HP:0003555) | 2.97910712 |
| 48 | Thick nail (HP:0001805) | 2.92201409 |
| 49 | Myocardial infarction (HP:0001658) | 2.90879511 |
| 50 | Pustule (HP:0200039) | 2.88290700 |
| 51 | Autoimmune hemolytic anemia (HP:0001890) | 2.87664876 |
| 52 | Inflammation of the large intestine (HP:0002037) | 2.84946445 |
| 53 | Prostate neoplasm (HP:0100787) | 2.81057967 |
| 54 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.71154984 |
| 55 | Resting tremor (HP:0002322) | 2.69582174 |
| 56 | Eosinophilia (HP:0001880) | 2.63142102 |
| 57 | Gingival bleeding (HP:0000225) | 2.61825648 |
| 58 | Hemoptysis (HP:0002105) | 2.60313914 |
| 59 | Vacuolated lymphocytes (HP:0001922) | 2.59502633 |
| 60 | Frequent falls (HP:0002359) | 2.58180528 |
| 61 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.58078474 |
| 62 | Gingivitis (HP:0000230) | 2.57741592 |
| 63 | Hematochezia (HP:0002573) | 2.56727583 |
| 64 | Abnormality of the fingertips (HP:0001211) | 2.56688807 |
| 65 | Bundle branch block (HP:0011710) | 2.55935676 |
| 66 | Osteolytic defects of the hand bones (HP:0009699) | 2.55723782 |
| 67 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.55723782 |
| 68 | Interstitial pulmonary disease (HP:0006530) | 2.55593939 |
| 69 | Urticaria (HP:0001025) | 2.55266125 |
| 70 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.55185643 |
| 71 | Abnormality of T cells (HP:0002843) | 2.54479397 |
| 72 | Menstrual irregularities (HP:0000858) | 2.52426501 |
| 73 | Gastrointestinal inflammation (HP:0004386) | 2.51868580 |
| 74 | Increased connective tissue (HP:0009025) | 2.51859337 |
| 75 | Agammaglobulinemia (HP:0004432) | 2.51828344 |
| 76 | Gastrointestinal infarctions (HP:0005244) | 2.50784640 |
| 77 | Rhabdomyolysis (HP:0003201) | 2.49060434 |
| 78 | Ventricular tachycardia (HP:0004756) | 2.48392176 |
| 79 | Neck muscle weakness (HP:0000467) | 2.47218865 |
| 80 | Colitis (HP:0002583) | 2.46378117 |
| 81 | Subacute progressive viral hepatitis (HP:0006572) | 2.46086603 |
| 82 | Prolonged bleeding time (HP:0003010) | 2.45794576 |
| 83 | Acute myeloid leukemia (HP:0004808) | 2.44483426 |
| 84 | Abnormality of the calf musculature (HP:0001430) | 2.43623172 |
| 85 | Leukocytosis (HP:0001974) | 2.43413735 |
| 86 | Microcytic anemia (HP:0001935) | 2.42651321 |
| 87 | Truncal obesity (HP:0001956) | 2.40765499 |
| 88 | Hypergammaglobulinemia (HP:0010702) | 2.38091637 |
| 89 | Osteomyelitis (HP:0002754) | 2.37904831 |
| 90 | Epistaxis (HP:0000421) | 2.37448913 |
| 91 | Arterial thrombosis (HP:0004420) | 2.36113612 |
| 92 | Keratoconjunctivitis sicca (HP:0001097) | 2.32454091 |
| 93 | Myoglobinuria (HP:0002913) | 2.32379086 |
| 94 | Pulmonary infiltrates (HP:0002113) | 2.32074280 |
| 95 | IgM deficiency (HP:0002850) | 2.31983997 |
| 96 | Periodontitis (HP:0000704) | 2.29570763 |
| 97 | Parakeratosis (HP:0001036) | 2.29552550 |
| 98 | Dysmetric saccades (HP:0000641) | 2.28763100 |
| 99 | Axonal loss (HP:0003447) | 2.28091222 |
| 100 | Pulmonary embolism (HP:0002204) | 2.27976084 |
| 101 | Cone-rod dystrophy (HP:0000548) | 2.27513082 |
| 102 | Ulnar deviation of the wrist (HP:0003049) | 2.27428812 |
| 103 | Abnormality of T cell physiology (HP:0011840) | 2.26636695 |
| 104 | Increased variability in muscle fiber diameter (HP:0003557) | 2.26324244 |
| 105 | Gastrointestinal stroma tumor (HP:0100723) | 2.22861791 |
| 106 | Panhypogammaglobulinemia (HP:0003139) | 2.21987303 |
| 107 | Basal ganglia calcification (HP:0002135) | 2.21361830 |
| 108 | Increased IgM level (HP:0003496) | 2.19464385 |
| 109 | Fatigue (HP:0012378) | 2.18931622 |
| 110 | Petechiae (HP:0000967) | 2.17818227 |
| 111 | Abnormality of the prostate (HP:0008775) | 2.17165131 |
| 112 | Gangrene (HP:0100758) | 2.15739184 |
| 113 | Chest pain (HP:0100749) | 2.15058246 |
| 114 | Encephalitis (HP:0002383) | 2.13344366 |
| 115 | Abnormality of eosinophils (HP:0001879) | 2.12434479 |
| 116 | Chronic sinusitis (HP:0011109) | 2.12324809 |
| 117 | Purpura (HP:0000979) | 2.12225244 |
| 118 | Keratoconjunctivitis (HP:0001096) | 2.12098253 |
| 119 | Sudden death (HP:0001699) | 2.12017216 |
| 120 | Skin ulcer (HP:0200042) | 2.10908617 |
| 121 | Hypoalphalipoproteinemia (HP:0003233) | 2.10494177 |
| 122 | Thyroiditis (HP:0100646) | 2.10480770 |
| 123 | Round ear (HP:0100830) | 2.09864125 |
| 124 | Granulocytopenia (HP:0001913) | 2.08781053 |
| 125 | Aortic aneurysm (HP:0004942) | 2.03488774 |
| 126 | Hepatosplenomegaly (HP:0001433) | 2.01186867 |
| 127 | Rimmed vacuoles (HP:0003805) | 1.99761834 |
| 128 | Overgrowth (HP:0001548) | 1.99414598 |
| 129 | Abnormal platelet volume (HP:0011876) | 1.98714430 |
| 130 | Abnormality of the ischium (HP:0003174) | 1.97125146 |
| 131 | Poikilocytosis (HP:0004447) | 1.97069304 |
| 132 | Chronic diarrhea (HP:0002028) | 1.96556740 |
| 133 | Increased serum ferritin (HP:0003281) | 1.96073375 |
| 134 | Malignant hyperthermia (HP:0002047) | 1.95923232 |
| 135 | Sepsis (HP:0100806) | 1.94674688 |
| 136 | Areflexia of lower limbs (HP:0002522) | 1.91803083 |
| 137 | Peritonitis (HP:0002586) | 1.91665354 |
| 138 | Verrucae (HP:0200043) | 1.90972621 |
| 139 | Papilloma (HP:0012740) | 1.90972621 |
| 140 | Esophageal varix (HP:0002040) | 1.89864310 |
| 141 | Recurrent lower respiratory tract infections (HP:0002783) | 1.89778164 |
| 142 | Recurrent pneumonia (HP:0006532) | 1.88819736 |
| 143 | Systemic lupus erythematosus (HP:0002725) | 1.88037536 |
| 144 | Exercise-induced muscle cramps (HP:0003710) | 1.87974378 |
| 145 | Lymphopenia (HP:0001888) | 1.87701142 |
| 146 | Distal lower limb muscle weakness (HP:0009053) | 1.85946880 |
| 147 | Muscle hypertrophy of the lower extremities (HP:0008968) | 1.83703543 |
| 148 | Hyporeflexia of lower limbs (HP:0002600) | 1.83022631 |
| 149 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.82979177 |
| 150 | Facial diplegia (HP:0001349) | 1.82722347 |
| 151 | Hypoplastic ischia (HP:0003175) | 1.81500561 |
| 152 | Conjunctival telangiectasia (HP:0000524) | 1.81092846 |
| 153 | Distal lower limb amyotrophy (HP:0008944) | 1.80947218 |
| 154 | Tubulointerstitial nephritis (HP:0001970) | 1.80633995 |
| 155 | Myopathic facies (HP:0002058) | 1.80344064 |
| 156 | Portal hypertension (HP:0001409) | 1.79394223 |
| 157 | Biliary tract neoplasm (HP:0100574) | 1.78652791 |
| 158 | Abnormal finger flexion creases (HP:0006143) | 1.77751799 |
| 159 | Sandal gap (HP:0001852) | 1.76899318 |
| 160 | Right ventricular cardiomyopathy (HP:0011663) | 1.76855408 |
| 161 | Fair hair (HP:0002286) | 1.76737588 |
| 162 | Abnormality of potassium homeostasis (HP:0011042) | 1.74770029 |
| 163 | EMG: neuropathic changes (HP:0003445) | 1.74105656 |
| 164 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.73929165 |
| 165 | Thyroid carcinoma (HP:0002890) | 1.73746731 |
| 166 | Long clavicles (HP:0000890) | 1.71884419 |
| 167 | Cystic hygroma (HP:0000476) | 1.67434463 |
| 168 | Postural instability (HP:0002172) | 1.66521214 |
| 169 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.66291848 |
| 170 | Thickened calvaria (HP:0002684) | 1.62583617 |
| 171 | Viral hepatitis (HP:0006562) | 1.60714110 |
| 172 | Prominent nose (HP:0000448) | 1.59864542 |
| 173 | Generalized muscle weakness (HP:0003324) | 1.59457959 |
| 174 | Increased CSF protein (HP:0002922) | 1.58617933 |
| 175 | Dilated cardiomyopathy (HP:0001644) | 1.58484768 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 3.37675289 |
| 2 | MAP3K14 | 2.80459175 |
| 3 | TXK | 2.68927740 |
| 4 | TYK2 | 2.67517353 |
| 5 | BRD4 | 2.65695914 |
| 6 | EPHB1 | 2.64901822 |
| 7 | JAK3 | 2.49775772 |
| 8 | IKBKE | 2.44566057 |
| 9 | BLK | 2.42983733 |
| 10 | PBK | 2.40357298 |
| 11 | TBK1 | 2.35437723 |
| 12 | IRAK4 | 2.34542661 |
| 13 | CLK1 | 2.26708926 |
| 14 | STK10 | 2.15009177 |
| 15 | CDK12 | 2.13002005 |
| 16 | PLK4 | 2.11900454 |
| 17 | STK38L | 2.04644106 |
| 18 | MST4 | 2.02198235 |
| 19 | JAK1 | 2.02126112 |
| 20 | LATS1 | 1.96635800 |
| 21 | RIPK4 | 1.81733295 |
| 22 | CAMK1G | 1.77865482 |
| 23 | MAP3K2 | 1.76831619 |
| 24 | FGFR4 | 1.75106928 |
| 25 | TGFBR2 | 1.74565298 |
| 26 | IRAK3 | 1.73782131 |
| 27 | AKT3 | 1.72794765 |
| 28 | CSK | 1.67291955 |
| 29 | EPHA3 | 1.63309561 |
| 30 | KIT | 1.60753162 |
| 31 | NLK | 1.59661952 |
| 32 | IKBKB | 1.59062836 |
| 33 | TTN | 1.57651330 |
| 34 | ZAP70 | 1.54932184 |
| 35 | TEC | 1.52624442 |
| 36 | FGFR3 | 1.52439634 |
| 37 | ITK | 1.51478240 |
| 38 | NME2 | 1.48332310 |
| 39 | SGK2 | 1.47673445 |
| 40 | TRPM7 | 1.46613689 |
| 41 | BTK | 1.43507359 |
| 42 | NEK9 | 1.40461709 |
| 43 | SGK3 | 1.40084261 |
| 44 | KSR2 | 1.40044241 |
| 45 | STK38 | 1.37885811 |
| 46 | STK4 | 1.37219050 |
| 47 | STK39 | 1.32102190 |
| 48 | LCK | 1.26628205 |
| 49 | FGR | 1.24444323 |
| 50 | PIM1 | 1.23833240 |
| 51 | SYK | 1.20552659 |
| 52 | GRK6 | 1.19272994 |
| 53 | HCK | 1.18506639 |
| 54 | ACVR1B | 1.16598592 |
| 55 | MAP3K13 | 1.16478659 |
| 56 | LRRK2 | 1.13610796 |
| 57 | JAK2 | 1.13387817 |
| 58 | EEF2K | 1.11809847 |
| 59 | PRPF4B | 1.08896457 |
| 60 | TAOK3 | 1.07259720 |
| 61 | IRAK1 | 1.04109009 |
| 62 | PRKCQ | 1.03789899 |
| 63 | PRKAA2 | 1.03420032 |
| 64 | MAP2K3 | 0.98595844 |
| 65 | NEK6 | 0.98008488 |
| 66 | DMPK | 0.97434994 |
| 67 | ERN1 | 0.94389500 |
| 68 | MARK3 | 0.93681659 |
| 69 | MAP3K6 | 0.91949689 |
| 70 | BMPR2 | 0.89108197 |
| 71 | CSF1R | 0.88217568 |
| 72 | PHKG2 | 0.87882631 |
| 73 | PHKG1 | 0.87882631 |
| 74 | PTK2B | 0.87759475 |
| 75 | MAP3K10 | 0.87582277 |
| 76 | LYN | 0.87297578 |
| 77 | TLK1 | 0.85283768 |
| 78 | MELK | 0.85230301 |
| 79 | PRKD2 | 0.85181776 |
| 80 | CHUK | 0.84035825 |
| 81 | HIPK2 | 0.82982310 |
| 82 | CDK6 | 0.82386195 |
| 83 | OBSCN | 0.81404840 |
| 84 | PIM2 | 0.79049797 |
| 85 | NUAK1 | 0.76861443 |
| 86 | PDPK1 | 0.74619962 |
| 87 | MST1R | 0.73870780 |
| 88 | TNK2 | 0.73680082 |
| 89 | BRSK2 | 0.72337260 |
| 90 | MAPK7 | 0.71868022 |
| 91 | PNCK | 0.71441319 |
| 92 | GRK7 | 0.71040788 |
| 93 | MAPKAPK5 | 0.70899474 |
| 94 | EIF2AK3 | 0.69163827 |
| 95 | PDGFRA | 0.68474537 |
| 96 | SGK494 | 0.67938334 |
| 97 | SGK223 | 0.67938334 |
| 98 | RAF1 | 0.67741691 |
| 99 | MAPK12 | 0.67618757 |
| 100 | FES | 0.65872323 |
| 101 | RPS6KA5 | 0.65155574 |
| 102 | PKN1 | 0.61358198 |
| 103 | KDR | 0.60933740 |
| 104 | STK3 | 0.60872120 |
| 105 | MARK2 | 0.60686315 |
| 106 | ABL1 | 0.57783527 |
| 107 | SGK1 | 0.57601771 |
| 108 | RPS6KA4 | 0.56012684 |
| 109 | FGFR2 | 0.53768798 |
| 110 | RET | 0.53583197 |
| 111 | MAP2K4 | 0.53190554 |
| 112 | PLK2 | 0.53171221 |
| 113 | MAPKAPK2 | 0.52741762 |
| 114 | EIF2AK2 | 0.51911627 |
| 115 | PRKD1 | 0.51850590 |
| 116 | CAMK4 | 0.51423233 |
| 117 | MAP3K7 | 0.50786329 |
| 118 | RPS6KB2 | 0.49076739 |
| 119 | DYRK1B | 0.48269070 |
| 120 | PIK3CG | 0.47745901 |
| 121 | PTK6 | 0.45755397 |
| 122 | PDGFRB | 0.45440128 |
| 123 | IRAK2 | 0.45179202 |
| 124 | FRK | 0.44204894 |
| 125 | MTOR | 0.44113824 |
| 126 | EIF2AK1 | 0.44094970 |
| 127 | BMX | 0.42244211 |
| 128 | PIK3CA | 0.42078825 |
| 129 | EGFR | 0.41356351 |
| 130 | PDK1 | 0.39908340 |
| 131 | TIE1 | 0.39864757 |
| 132 | CDK4 | 0.39528898 |
| 133 | MAPK11 | 0.39081211 |
| 134 | WNK1 | 0.38734656 |
| 135 | STK24 | 0.38686969 |
| 136 | PRKG2 | 0.38584595 |
| 137 | MAP3K1 | 0.38348991 |
| 138 | MAP3K3 | 0.37969012 |
| 139 | YES1 | 0.37847408 |
| 140 | MAPK4 | 0.37219471 |
| 141 | OXSR1 | 0.36820253 |
| 142 | CAMK1D | 0.35760389 |
| 143 | KSR1 | 0.35627634 |
| 144 | MAP3K11 | 0.35096414 |
| 145 | PKN2 | 0.34983696 |
| 146 | MOS | 0.33996391 |
| 147 | FYN | 0.33492255 |
| 148 | GSK3A | 0.33026317 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Leishmaniasis_Homo sapiens_hsa05140 | 2.86688289 |
| 2 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.82074060 |
| 3 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.63413164 |
| 4 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.61086873 |
| 5 | Measles_Homo sapiens_hsa05162 | 2.61047329 |
| 6 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.46842833 |
| 7 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.36900039 |
| 8 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.34120774 |
| 9 | Malaria_Homo sapiens_hsa05144 | 2.33519579 |
| 10 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.32064547 |
| 11 | Allograft rejection_Homo sapiens_hsa05330 | 2.27781198 |
| 12 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.24899123 |
| 13 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.15423703 |
| 14 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.04367127 |
| 15 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.98399243 |
| 16 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.96518650 |
| 17 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.95305316 |
| 18 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.88786239 |
| 19 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.88169979 |
| 20 | Pertussis_Homo sapiens_hsa05133 | 1.81951696 |
| 21 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.80513230 |
| 22 | Influenza A_Homo sapiens_hsa05164 | 1.65441650 |
| 23 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.64581532 |
| 24 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.63549094 |
| 25 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.63174751 |
| 26 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.60684136 |
| 27 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.60484858 |
| 28 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.59959442 |
| 29 | Legionellosis_Homo sapiens_hsa05134 | 1.59935625 |
| 30 | Asthma_Homo sapiens_hsa05310 | 1.58655518 |
| 31 | Tuberculosis_Homo sapiens_hsa05152 | 1.58512224 |
| 32 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.50891684 |
| 33 | Circadian rhythm_Homo sapiens_hsa04710 | 1.47700698 |
| 34 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.43331961 |
| 35 | Salmonella infection_Homo sapiens_hsa05132 | 1.42056058 |
| 36 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.38789636 |
| 37 | Viral myocarditis_Homo sapiens_hsa05416 | 1.38733919 |
| 38 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 1.38253781 |
| 39 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.37826041 |
| 40 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.37162630 |
| 41 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.36721896 |
| 42 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.31893547 |
| 43 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.24451403 |
| 44 | Hepatitis B_Homo sapiens_hsa05161 | 1.22695768 |
| 45 | Endometrial cancer_Homo sapiens_hsa05213 | 1.21021806 |
| 46 | Hepatitis C_Homo sapiens_hsa05160 | 1.20353615 |
| 47 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.18432687 |
| 48 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.17149542 |
| 49 | Apoptosis_Homo sapiens_hsa04210 | 1.16247977 |
| 50 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.14468791 |
| 51 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.14092310 |
| 52 | Shigellosis_Homo sapiens_hsa05131 | 1.12638968 |
| 53 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.12358043 |
| 54 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 1.11252525 |
| 55 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.07389997 |
| 56 | Thyroid cancer_Homo sapiens_hsa05216 | 1.05753088 |
| 57 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.05733215 |
| 58 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.00303290 |
| 59 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.00265723 |
| 60 | Glioma_Homo sapiens_hsa05214 | 0.99837775 |
| 61 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.99525063 |
| 62 | Long-term potentiation_Homo sapiens_hsa04720 | 0.96916477 |
| 63 | Platelet activation_Homo sapiens_hsa04611 | 0.96533206 |
| 64 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.96306452 |
| 65 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.92861880 |
| 66 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.92791897 |
| 67 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.91947896 |
| 68 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.90415593 |
| 69 | Colorectal cancer_Homo sapiens_hsa05210 | 0.89385957 |
| 70 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.88168909 |
| 71 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.85172547 |
| 72 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.84481042 |
| 73 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.84347124 |
| 74 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.83321922 |
| 75 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.82327461 |
| 76 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.81621369 |
| 77 | Renin secretion_Homo sapiens_hsa04924 | 0.80700755 |
| 78 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.79630805 |
| 79 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.77554325 |
| 80 | Amoebiasis_Homo sapiens_hsa05146 | 0.77341437 |
| 81 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.77291611 |
| 82 | Lysosome_Homo sapiens_hsa04142 | 0.76503044 |
| 83 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.75686290 |
| 84 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.72989207 |
| 85 | Phagosome_Homo sapiens_hsa04145 | 0.71439252 |
| 86 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.70655000 |
| 87 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.67735408 |
| 88 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.67264325 |
| 89 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.66273156 |
| 90 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.65566094 |
| 91 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.64366492 |
| 92 | ABC transporters_Homo sapiens_hsa02010 | 0.63938554 |
| 93 | Tight junction_Homo sapiens_hsa04530 | 0.62759154 |
| 94 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.62038592 |
| 95 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.61873412 |
| 96 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.61123755 |
| 97 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.60760629 |
| 98 | Long-term depression_Homo sapiens_hsa04730 | 0.59138061 |
| 99 | Prostate cancer_Homo sapiens_hsa05215 | 0.59050049 |
| 100 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.58768100 |
| 101 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.57196526 |
| 102 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.54575716 |
| 103 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.52941482 |
| 104 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.52013113 |
| 105 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.51829978 |
| 106 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.51777171 |
| 107 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.51683467 |
| 108 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.51593578 |
| 109 | Insulin resistance_Homo sapiens_hsa04931 | 0.51398527 |
| 110 | Other glycan degradation_Homo sapiens_hsa00511 | 0.48873087 |
| 111 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.47201467 |
| 112 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.46064717 |
| 113 | Adherens junction_Homo sapiens_hsa04520 | 0.45651214 |
| 114 | Endocytosis_Homo sapiens_hsa04144 | 0.45592467 |
| 115 | Focal adhesion_Homo sapiens_hsa04510 | 0.45005512 |
| 116 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.44568203 |
| 117 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.43453327 |
| 118 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.42850224 |
| 119 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.42141894 |
| 120 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.41262110 |
| 121 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.41021574 |
| 122 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.40389814 |
| 123 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.39003841 |
| 124 | HTLV-I infection_Homo sapiens_hsa05166 | 0.38126894 |
| 125 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.37403769 |
| 126 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.37195326 |
| 127 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.35416085 |
| 128 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.33150487 |
| 129 | Mineral absorption_Homo sapiens_hsa04978 | 0.31010826 |
| 130 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.30351600 |
| 131 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.28314534 |
| 132 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.28173030 |
| 133 | Pathways in cancer_Homo sapiens_hsa05200 | 0.26367954 |
| 134 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.23613158 |
| 135 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.23455965 |
| 136 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.22737573 |

